162,163,164 Exa-cel (Casgevy) was approved in November 2023 as the first gene-editing therapeutic drug based on the CRISPR/Cas9 system for treating sickle cell disease (SCD) and transfusion-dependent -thalassemia (TDT)
Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells
Associations of midlife to late-life fatigue with physical performance and strength in early old age: Results from a British prospective cohort study
What separates them is what happens after that activation
Carnitine homeostasis is meticulously regulated by a network of membrane transporters, with OCTN2 playing a key role in its absorption, reabsorption, and distribution
L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial